[3] DPP-4 is a dipeptidase that selectively binds substrates that contain proline at the P1-position, thus many DPP-4 inhibitors have 5-membered heterocyclic rings that mimic proline, e } : CS1 maint: deprecated archival service (link) Current Topics in Medicinal Chemistry , 7 (6): 597608, doi:10.2174/156802607780090993, PMID 17352680 Current Topics in Medicinal Chemistry , 7 (6): 557568, doi:10.2174/156802607780091028, PMID 17352677 1 2 3 "Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use", Clinical Diabetes , 26 (2): 5357, doi:10.2337/diaclin.26.2.53, retrieved 29 July 2013 Bioorganic & Medicinal Chemistry Letters , 17 (20): 56385642, doi:10.1016/j.bmcl.2007.07.081, PMID 17822893 Bioorganic & Medicinal Chemistry Letters , 15 (21): 47704773, doi:10.1016/j.bmcl.2005.07.026, PMID 16115768 Current Topics in Medicinal Chemistry , 7 (6): 569578, doi:10.2174/156802607780091073, PMID 17352678 1 2 Diabetologia , 50 (1 Supp): S362S363, doi:10.1007/s00125-007-0809-7, PMID 17710465, ProQuest 213848837 (registration required) Journal of Medicinal Chemistry , 50 (10): 22972300, doi:10.1021/jm070104l, PMID 17441705 FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP- 4 agent for Type 2 Diabetes , retrieved 29 July 2013

A thorough medical evaluation by a qualified provider is essential before starting treatment
A bit of foresight here can go a long way towards preventing backsliding and encouraging easy bounce back
Despite the lower percentage of employers reporting that they saw an increase in the share of employees using services for substance-abuse-related conditions, there is concern among employers that substance abuse has grown among their employees since the COVID-19 pandemic began
Therapy duration did not vary by IBS subtype (P=0.59)